Arrayjet today announced that the company has launched its custom microarray services offering. Arrayjet entered the microarray market in 2005, when it launched the first of its suite of four microarrayers based on the company’s unique non-contact technology. Since then, the company has sold over forty instruments worldwide, to customers working in such prestigious organisations as The Roslin Institute, The Medical Research Council of Great Britain, EMBL, Cornell University, Millipore, Novartis and CalTech.
Speaking about the company’s expansions plans, Duncan Hall, Arrayjet’s Commercial Director, said: "To date, Arrayjet has been focused on delivering its core microarray printing products based on its unique inkjet technology. Throughout this time we have had numerous enquiries from researchers who have wanted to access our printing technology and microarray development expertise on a “usage” basis. We are now addressing this demand and have already signed up our first customers.”
Arrayjet will continue to manufacture and sell instruments, with the custom microarray services enabling the company to meet the needs of a broader selection of customers. Hall continued: “We will be investing considerable resources in our custom microarray services, which we believe will be the broadest and most flexible available. Indeed we will also offer a hybrid business model: customers can initially work with us on assay development and custom microarray printing, before electing to take control of production in their own facility when they are ready; Arrayjet will then transfer the entire production solution as part of the service.”
Arrayjet’s products include the Marathon Inkjet Microarrayer - the company’s first product, launched as the Aj100 - soon followed by the Super-Marathon (Aj120) and the Sprint. Later models included the Ultra-Marathon and Ultra-Marathon II Inkjet Microarrayers, both of which are capable of printing microarrays on up to 1,000 slides in a single, fully automated print run.
Arrayjet
